Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial

NCT01962571 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Optic Neuritis

Interventions

DRUG: Erythropoietin alfa
DRUG: Placebo

Sponsor

University Eye Hospital, Freiburg

Collaborators

[object Object]